Antibiotic

Mutalomycin is a polyether antibiotic targeting Gram-positive bacteria, mycoplasma, and coccidia. It exhibits significant antibacterial and antiparasitic activity, making it a valuable tool for studies involving bacterial infections and coccidiosis. Its efficacy in inhibiting microbial growth supports its application in microbiological research and the development of therapeutic interventions.

Piericidin B is an antibiotic targeting bacterial cells with potent antimicrobial properties. It exhibits strong antibacterial activity, making it a valuable tool in the study of antibacterial mechanisms and the development of new antibiotic therapies. Research applications include assessing its efficacy against various bacterial strains and understanding its role in natural antibiotic production.

Endophenazine B is a phenazine antibiotic primarily known for its antibacterial properties. It exhibits low herbicidal activity against the aquatic plant Lemna minor, making it a useful tool for studying microbial interactions and plant-pathogen dynamics. This compound serves as a valuable research agent for investigations into antibiotic efficacy and resistance mechanisms.

Porothramycin A is an antibiotic that primarily targets Gram-positive and anaerobic bacteria. It exhibits significant antibacterial activity, making it a valuable compound for research focused on bacterial infections and antibiotic resistance. This reagent is suitable for studies aimed at understanding microbial pathogenesis and developing novel antimicrobial therapies.

Polymyxin A1 is a heteropeptide antibiotic that primarily targets the outer membrane of Gram-negative bacteria. It exhibits significant antibacterial activity, making it an important reagent in studying bacterial membrane dynamics and resistance mechanisms. Its selective efficacy against Gram-negative pathogens positions Polymyxin A1 as a valuable tool in microbiological research and antibiotic development.

23-De(mycinosyloxy)tylosin is a macrolide antibiotic that primarily targets Gram-positive bacteria. It exhibits antibacterial activity against a range of both Gram-positive and mycoplasma species, while showing limited effectiveness against Gram-negative bacteria. This compound is utilized in microbiological research to study antibiotic resistance and the mechanisms of bacterial inhibition.

Maridomycin V is a macrolide antibiotic that targets Gram-positive bacteria and mycoplasma. It exhibits potent antibacterial activity, demonstrating efficacy in protecting murine models from Gram-positive bacterial infections. This compound is valuable for research applications focusing on antibacterial activity and the mechanisms of resistance in Gram-positive pathogens.

Permetin A is a peptide antibiotic that exerts its antibacterial effects by targeting and disrupting bacterial cell membranes. This compound demonstrates significant activity against Gram-negative bacteria, Gram-positive bacteria, and anaerobic bacteria, making it a valuable tool for researchers studying bacterial resistance mechanisms and developing new antimicrobial therapies. Its broad-spectrum efficacy positions Permetin A as a potent candidate for further exploration in the field of microbiological research.

7β,8β-2′,3′-Diepoxyroridin H is an antibiotic that exhibits activity against both Gram-positive and Gram-negative bacteria. Its broad-spectrum efficacy makes it a valuable tool for studying bacterial resistance mechanisms and antibiotic susceptibility in various research applications.

Depsidomycin is an immunomodulating antibiotic that exhibits immunosuppressive activity. Isolated from Streptomyces lavendofoliae MI951-62F2, it demonstrates potent antibacterial effects against Gram-positive bacteria. This compound is valuable for research applications focusing on the modulation of immune responses and the inhibition of bacterial growth.

Halomicin B is an ansamycin antibiotic that targets bacterial RNA polymerase, inhibiting transcription. It exhibits antimicrobial activity against a variety of Gram-positive and Gram-negative bacteria, making it a valuable reagent for studies involving bacterial infections. Its efficacy in selectively disrupting bacterial growth positions Halomicin B as a critical tool in antibiotic research and development.

Aurein 2.1 is an antibiotic peptide derived from the skin secretions of Australian Bell Frogs, specifically Litoria aurea and Litoria raniformis. It exhibits significant antimicrobial activity against a range of bacterial strains, making it a valuable tool for research in antibiotic development and investigations into novel antimicrobial mechanisms. This peptide is of particular interest for studies related to infection control and the exploration of natural antimicrobial agents.

Cytosaminomycin A is an antibiotic that exhibits potent anticoccidial and antibacterial activities. This compound is utilized in research studies to explore its efficacy against various pathogens, making it valuable in the field of microbiology and infectious disease research. Its unique mechanisms may provide insights into antibiotic resistance and potential therapeutic applications.

Epoxyquinomicin A is an antibiotic derived from the bacterium Amycolatopsis sp., exhibiting significant antimicrobial activity against various pathogens including Micrococcus luteus, Bacillus subtilis, Pasteurella piscicida, and Staphylococcus aureus, with minimum inhibitory concentrations (MIC) ranging from 3 to 12.5 µg/mL. Additionally, Epoxyquinomicin A demonstrates cytotoxic effects on cancer cell lines such as L1210, B16, and S180, with IC50 values between 2 and 8 µg/mL. Its anti-inflammatory properties have also been noted, particularly in models of collagen-induced arthritis, making it a valuable reagent for research in microbiology and oncology.

Mycinamicin VII is a macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. It demonstrates significant antibacterial activity against Gram-positive bacteria, making it a valuable tool for research in microbiology and antimicrobial therapy. Its efficacy in inhibiting the growth of various pathogenic strains underscores its potential for further investigation in antibiotic resistance studies.

Bactobolin hydrochloride is an antibiotic that exhibits potent inhibitory activity against a range of gram-negative and gram-positive bacteria, including Escherichia coli, Salmonella, Shigella, Staphylococcus, and Bacillus subtilis, with minimum inhibitory concentrations (MICs) ranging from 0.3 to 6.25 μg/mL. Additionally, Bactobolin hydrochloride demonstrates antitumor activity against leukemia, showing a median lethal dose (LD50) of 6.25 to 12.5 mg/kg. This compound is valuable for research in microbiology and cancer therapeutics.

Clavamycin F is a clavam antibiotic that inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins. It demonstrates significant antibacterial activity against a range of Gram-positive bacteria. This compound is utilized in research applications aimed at understanding antibiotic resistance mechanisms and developing new therapeutic strategies against bacterial infections.

3-O-α-D-Forosaminyl-(+)-griseusin is a naphthoquinone antibiotic that primarily targets Gram-positive bacteria. It exhibits potent activity against various strains, including methicillin-resistant Staphylococcus aureus (MRSA). This compound serves as an important tool in antimicrobial research and the development of new therapeutic strategies against resistant bacterial infections.

Griseusin B is a quinone antibiotic that primarily targets Gram-positive bacteria. Its significant antibacterial activity makes it a valuable tool in research focused on infectious diseases and antibiotic resistance mechanisms. Griseusin B can be utilized to study bacterial susceptibility and the effects of antibiotic treatment in various biological systems.

L-threo-β-Hydroxyaspartic acid is an amino acid antibiotic that targets bacterial cell metabolism. It has demonstrated efficacy in inhibiting the growth of several pathogens, including Bacillus subtilis, Xanthomonas oryzae, Mycobacterium phlei, and Botrytis cinerea. This compound is valuable for research applications focused on microbiology and antibiotic resistance studies.

Argimicin A is an antibiotic isolated from Sphingomonas sp. It demonstrates significant algicidal activity against toxic cyanobacteria and effectively inhibits Microcystis viridis and Microcystis aeruginosa, with IC50 values of 12 ng/mL and 100 ng/mL, respectively. This compound is valuable for research on algal blooms and the study of antibiotic mechanisms in aquatic environments.

Amythiamicin B is a trisubstituted pyridine thiopeptide that functions as an antibiotic primarily targeting Gram-positive bacteria. Additionally, it exhibits activity against Plasmodium falciparum, making it relevant for research on malaria. Its unique structural attributes allow it to be a valuable tool in the study of antimicrobial resistance and the development of new therapeutic strategies.

Olivanic acid is a β-lactam antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antimicrobial activity against both Gram-positive and Gram-negative bacteria by inhibiting β-lactamase enzymes. This makes it a valuable compound for research applications in antibiotic resistance studies and the development of novel antimicrobial therapies.

Macquarimicin C is a potent antibiotic that targets bacterial ribosomal function. It exhibits significant antibacterial activity against a range of Gram-positive and Gram-negative pathogens. This compound is valuable for research applications related to antimicrobial resistance and the study of ribosome-inhibiting antibiotics.

Obafluorin is a β-Lactone Antibiotic known for its potent antibacterial activity against a variety of Gram-positive and Gram-negative bacteria. This compound, originally produced by Pseudomonas fluorescens ATCC 39502, effectively inhibits E. coli threonyl-tRNA synthetase, making it a valuable tool for research in microbiology and antibiotic development. Its unique mechanism of action underscores its potential in studying bacterial resistance and antibiotic efficacy.

Leucinostatin H is a polypeptide antibiotic derived from Paecilomyces marquandii, featuring a tertiary amine-oxide terminal group. It demonstrates potent inhibitory activity against Gram-positive bacteria, including Bacillus subtilis, B. cereus, and Staphylococcus aureus, with minimum inhibitory concentrations ranging from 10 to 100 μg/mL. Leucinostatin H is valuable for research applications in anti-infective therapies and plant disease management.

8"-Hydroxypactamycin is an antibiotic derived from Streptomyces SIPI-A-3-0121, primarily targeting bacterial protein synthesis. It exhibits potent antibacterial activity, making it a valuable tool for investigating bacterial resistance mechanisms and developing new antimicrobial strategies. Its unique structure and mechanism of action present opportunities for research in antibiotic efficacy and therapeutic applications.

Mycinamicin IV is an ester peptide antibiotic that targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable tool in the study of bacterial infection mechanisms and the development of new antimicrobial compounds. Mycinamicin IV is instrumental in research applications focused on antibiotic resistance and microbial pathogenesis.

Clavamycin E is a clavam antibiotic that targets bacterial cell wall synthesis. It exhibits potent antimicrobial activity against a range of Gram-positive bacteria, making it a valuable tool in studying bacterial resistance mechanisms. This compound is utilized in research applications focused on antibiotic development and the exploration of novel therapeutic strategies against resistant strains.

BK-218 is an orally active cephalosporin antibiotic that targets penicillin-binding proteins (PBPs). It demonstrates a potent inhibitory effect, surpassing that of Cephalexin and Cefoxitin, while exhibiting antibacterial activity comparable to Cefamandole. BK-218 is a valuable compound in the development of novel antibacterial therapies.

TAN-1057C is a potent antibiotic that targets bacterial cell wall synthesis, demonstrating remarkable antibacterial activity against both Gram-negative and Gram-positive bacteria. Notably, TAN-1057C effectively combats Methicillin-resistant Staphylococcus aureus, making it a valuable tool in research focusing on antibiotic resistance and bacterial infections. This compound is essential for studies exploring new therapeutic strategies and mechanisms of action against resistant bacterial strains.

Nortopixantrone is a 9-aza-anthrapyrazole-based antineoplastic antibiotic that targets tumor cell proliferation. It exhibits potent cytotoxic activity against various cancer types, making it a valuable tool in oncological research. Nortopixantrone is utilized in studies to explore mechanisms of action related to DNA intercalation and topoisomerase inhibition, contributing to advancements in cancer therapeutics.

Hydroxynybomycin is an antibiotic that targets and inhibits the growth of Gram-negative bacteria. This compound exhibits significant antibacterial activity, making it a valuable tool in research applications aimed at understanding bacterial resistance mechanisms and developing new antimicrobial therapies. Hydroxynybomycin's efficacy against a range of pathogenic strains positions it as a critical reagent for studies in microbiology and infectious disease research.

Pyrrolomycin D is a member of the pyrrolomycin class of antibiotics, derived from Actinosporangium species. It exhibits potent antibacterial activity against a range of Gram-positive bacteria through its inhibition of protein synthesis. This compound is of significant interest in microbiological research and antibiotic development studies, providing valuable insights into the mechanisms of antibiotic resistance and the potential for new therapeutic agents.

Leucomycin V is a macrolide antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. It exhibits strong antibacterial activity against Gram-positive bacteria and demonstrates efficacy against spirochetes, Rickettsia, and Chlamydia species. This compound is primarily utilized in microbiological research to investigate bacterial resistance mechanisms and the development of new therapeutic strategies.

Aspiculamycin is a nucleoside-derived antibiotic exhibiting a broad spectrum of antibacterial activity. It targets bacterial ribosomal protein synthesis, disrupting essential cellular processes. This compound is utilized in research to investigate bacterial resistance mechanisms and the efficacy of antimicrobial agents. Its unique mode of action makes it a valuable tool in the study of bacterial pathogens and the development of new antibiotics.

1-Hydroxysulfurmycin B is an anthracycline antibiotic that targets bacterial cell functions. It exhibits notable antibacterial activity against Gram-positive bacteria and demonstrates anti-tumor effects in various cancer cell lines. This compound is useful in research applications investigating antibiotic resistance and cancer therapeutics.

Altromycin E is an antibiotic that primarily targets bacterial pathogens, demonstrating significant antibacterial activity against Streptococci and Staphylococci with a minimum inhibitory concentration (MIC) ranging from 0.2 to 3.12 μg/mL. Additionally, its properties make it a valuable compound for anti-tumor research applications.

Chuangxinmycin is an antibiotic derived from Actinoplanes tsinanensis CPCC 200056, targeting bacterial infections. It demonstrates significant antibacterial activity in both in vitro and in vivo systems, making it a valuable tool for research on infections and antibiotic efficacy. Researchers can employ Chuangxinmycin to explore mechanisms of action and resistance in bacterial pathogens.

CF3–K11 is a stable antibiotic that targets bacterial growth. It exhibits potent antibacterial activity against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA). This compound is suitable for research applications focused on antibiotic resistance and the development of novel therapeutic strategies.

Arizonin A1 is an antibiotic that specifically targets Gram-positive bacteria. This microbial metabolite demonstrates potent antibacterial activity, making it a valuable tool for research in microbiology and antibiotic drug development. Its effectiveness against Gram-positive pathogens positions Arizonin A1 as an important compound for studies focused on bacterial resistance and therapeutic interventions.

3-O-Demethylmonensin B is a polyether antibiotic that targets a range of Gram-positive bacteria. This compound is derived from Streptomyces cinnamonensis LO-63 and exhibits potent antimicrobial activity. It is primarily utilized in microbiological studies and antibiotic research to explore its effects and mechanisms of action against resistant bacterial strains.

Endophenazine C is a phenazine antibiotic that functions by inhibiting bacterial DNA synthesis. It demonstrates potent antimicrobial activity against a range of Gram-positive and Gram-negative bacteria. This compound is primarily utilized in microbiological research to investigate bacterial resistance mechanisms and the development of novel antimicrobial agents.

Pluracidomycin B is a carbapenem antibiotic that targets bacterial cell wall synthesis. It exhibits antibacterial activity against both Gram-positive and Gram-negative bacteria and is capable of inhibiting β-lactamase enzymes. This compound is valuable in microbiological research for investigating antibiotic resistance and evaluating bacterial susceptibility.

Gentamicin X2 is a minor aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits potent antibacterial activity against a broad spectrum of Gram-negative and some Gram-positive bacteria. Gentamicin X2 is commonly utilized in microbiology research to study bacterial resistance mechanisms and to evaluate antibiotic efficacy in various therapeutic contexts.

Demethylolivomycin A is an antitumor antibiotic that primarily targets cancer cells through its ability to interfere with DNA synthesis. It exhibits significant activity against Gram-positive bacteria and demonstrates efficacy against leukemia cell lines, including P388. This compound is valuable for research focused on developing new chemotherapeutic agents and exploring antibiotic mechanisms.

Hydroxymycotrienin A is an Ansa antibiotic that targets tumor cells by inhibiting their proliferation. It demonstrates potent antitumor activity, particularly against human neck tumor cell lines, showing enhanced efficacy against human papillomavirus (HPV) gene-positive cells such as HeLa, CaSKi, and SiHa, compared to HPV gene-negative counterparts. This compound is valuable for research in cancer therapeutics and the study of HPV-related oncogenesis.

10-Decarbomethoxyaclacinomycin A is an anthracycline antibiotic that functions through the inhibition of nucleic acid synthesis. Produced by the Streptomyces galilaeus MA144-Mlt mutant strain KE303, this compound exhibits notable antibacterial activities. It is valuable for research applications focused on understanding antibacterial mechanisms and exploring potential therapeutic interventions for bacterial infections.

RPR 102341 is an antibiotic that demonstrates structural similarity to the fluoroquinolone class. It exhibits significant antibacterial activity by inhibiting bacterial DNA gyrase and topoisomerase IV, leading to disruption of DNA replication and transcription. This compound is primarily utilized in research applications focused on antibiotic resistance mechanisms and the development of novel antimicrobial agents.

Sannamycin L is an aminoglycoside antibiotic that targets bacterial protein synthesis. It exhibits weak antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a subject of interest for studying bacterial resistance mechanisms and antibiotic efficacy. This compound can be utilized in research applications focused on the development of new antimicrobial agents.